Prostate specific membrane antigen (PSMA) is expressed in normal prostate epithelial cells and strongly up regulated in initial and advanced prostate carcinoma. Therefore
PSMA is an attractive molecular target for the detection of primary and metastatic lesions. It plays an important role in the diagnosis
staging
prognostic evaluation and targeted treatment in prostate carcinoma patients. This review will summarize the progress of small molecular radionuclide probes
FAPI in radionuclide theranostics: toward a new emerging paradigm for tumor management
A case of 18F-PSMA-3Q PET/MRI in the diagnosis of glioblastoma multiforme of the brain
Multimodality imaging for the evaluation of immune checkpoint inhibitor-related myocarditis
The diagnostic value of molecular imaging in treatment-related cardiotoxicity of malignancy
Advances in FAP-targeted molecular imaging probes for disease detection
Related Author
Hui YANG
Ying DING
Yang GAO
Ming QI
Xiaosheng LIU
Shaoli SONG
Meng XIAO
Yipeng GAO
Related Institution
Key Laboratory of Precision Diagnosis and Treatment in Oncology Nuclear Medicine for Henan Provincial
Department of Nuclear Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Center for Biomedical Imaging, Fudan University, Shanghai Engineering Research Center of Molecular Imaging Probes
Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Department of Imaging Diagnosis, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, Inner Mongolia Autonomous Region